Capex S.A (CAPX.BA) stock: key figures, P/E, revenue and dividend
Industrials · Environmental & Facilities Services · Argentina · ISIN ARP2006N1025
Capex S.A financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 538.87 bn ARS | 600.89 bn ARS |
| Gross profit | 140.99 bn ARS | 199.76 bn ARS |
| Operating income | 31.67 bn ARS | 70.29 bn ARS |
| EBIT | 27.05 bn ARS | 119.79 bn ARS |
| Net income | 34.22 bn ARS | 45.91 bn ARS |
| Diluted EPS – continuing operations | 190.33 ARS | 255.34 ARS |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Capex S.A
Capex S.A., an integrated energy company, engages in the exploration and exploitation of hydrocarbons in Argentina. The company is involved in the exploration and exploitation of oil and gas; construction and development of a combined-cycle thermal power plant with an installed capacity of 672 MW and an LPG plant; production of hydrogen and oxygen; and production and sale of propane, butane, and gasoline, as well as generation of energy from wind farms and hydrogen/oxygen. It also processes and separates liquid gases derived from gas. The company was incorporated in 1988 and is based in Vicente López, Argentina. Capex S.A. is a subsidiary of Companias Asociadas Petroleras S.A.
More stocks
- Tianjin Hi-Tech Development Co Ltd (600082.SS)
- JSL S.A (JSLG3.SA)
- CION Investment Corp (CION)
- ASURE SOFTWARE INC (ASUR)
- VERRA MOBILITY Corp (VRRM)
- Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (300937.SZ)
- Evommune, Inc. (EVMN)
- Cabaletta Bio, Inc. (CABA)
- FRANKLIN FINANCIAL SERVICES CORP /PA/ (FRAF)
- Desiccant Technology Corporation (5292.TW)
- Daqing Huake Co Ltd (000985.SZ)
- cBrain A/S (CBRAIN.CO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.